Physician profile
Dana E Castro
NPI 1770501108
$1,516.49
in general payments reported to CMS, 2019-2025
16 companies · $759 in 2025
The $759 reported for 2025 was more than what 77% of Psychiatry providers received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $12.40 · 2022: $29.87 · 2023: $279 · 2024: $437 · 2025: $759.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,375 · Education: $99.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,374.72 |
| Education | $99.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $258.28 | 2022-2025 | Aristada, Lybalvi, Vivitrol |
| Janssen Pharmaceuticals, INC | $243.73 | 2023-2025 | Invega Sustenna, Invega Trinza |
| Teva Pharmaceuticals USA, INC. | $163.62 | 2025 | Austedo Xr |
| Neurocrine Biosciences, INC. | $154.43 | 2024-2025 | Ingrezza |
| Indivior INC. | $101.14 | 2023-2024 | Sublocade, Perseris |
| Otsuka America Pharmaceutical, INC. | $89.03 | 2021-2024 | Rexulti, Abilify Maintena |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $83.81 | 2024-2025 | Caplyta |
| Lundbeck LLC | $82.77 | 2023-2024 | Rexulti |
| Vanda Pharmaceuticals INC. | $76.81 | 2023-2025 | Fanapt, Hetlioz |
| Boston Scientific Corporation | $75.04 | 2025 | Wavewriter Alpha Prime 16 |
| Abbvie INC. | $73.75 | 2023-2024 | Vraylar |
| Braeburn INC. | $37.42 | 2023-2025 | Brixadi |
| E.R. Squibb & Sons, L.L.C. | $28.48 | 2025 | Cobenfy |
| Axsome Therapeutics, INC. | $23.73 | 2024 | Auvelity |
| Almatica Pharma LLC | $13.11 | 2024 | Loreev Xr |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $11.34 | 2024 | Azstarys |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dana Castro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.